Brief: TetraLogic says expects to start hep B trial in India by early 2016

Tetralogic Pharmaceuticals

20/07/2015 21:02

July 20 (Reuters) - TetraLogic Pharmaceuticals Corp  TLOG.O : 
 * Provides update on hepatitis b clinical program 
 * Currently expects to initiate this trial at multiple sites in India in early 
   2016 
 * Intends to initiate a combination single ascending dose/multiple ascending 
   dose clinical trial, with birinapant as a single agent 
 
 * Source text for Eikon  ID:nGNXVEAKNa  
 
 * Further company coverage  TLOG.O   
   ((Bengaluru Newsroom; +1 646 223 8780))